Hatib, Laina A.
HRN: 26-64-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
CEFUROXIME 500MG (TAB)
02/08/2025
02/16/2025
PO
500mg
BID
S/P Nsvd Non Intitutional Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes